SEC 13F Intelligence

Bml Capital Management, LLC / CLYM

Bml Capital Management, LLC’s Climb Bio Inc Position

Does Bml Capital Management, LLC own Climb Bio Inc (CLYM)? Not currently — the last reported position was 2.19M shares worth $6M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$6M
Q1 2024
Shares
2.19M
% of Portfolio
+3.96%
Quarters Held
6
position exited

Position History CLYM

Reported value by quarter
Q4 ’22: $7MQ4 ’22Q1 ’23: $5MQ1 ’23Q2 ’23: $4MQ2 ’23Q3 ’23: $5MQ3 ’23Q4 ’23: $6MQ4 ’23Q1 ’24: $6MQ1 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20242.19M$6M+3.96%
Q4 20232.18M$6M+4.46%
Q3 20231.94M$5M+4.68%
Q2 20231.58M$4M+3.99%
Q1 20231.66M$5M+4.16%
Q4 20221.83M$7M+6.40%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bml Capital Management, LLC’s full portfolio or all institutional holders of CLYM.